Streetbeat News

Stock Prices

LECO

Stifel has maintained its Hold rating for Lincoln Electric Holdings (NASDAQ:LECO) but increased its price target from $192.00 to $208.00. Despite the raised target, this still implies a potential downside of 5.45% from the current share price of $220.00. Lincoln Electric is a leading manufacturer in the welding industry, with a global presence and $3.8 billion in sales for 2022.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 5:00 pm

MC

Goldman Sachs has reaffirmed its Sell rating on Moelis & Co (NYSE:MC) but increased its price target from $41.00 to $47.00. Despite the upgrade in the price target, the new target still suggests a potential downside of 17.25% from the current share price of $56.80. Moelis & Co is an independent investment bank offering strategic and financial advice globally, with the majority of its revenue coming from the United States.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 5:00 pm

PRLD

Morgan Stanley has downgraded Prelude Therapeutics (NASDAQ:PRLD) from an unspecified rating to Underweight, slashing the price target from $10.00 to $4.00. Despite the downgrade, PRLD shares remained stable over the last 24 hours at $4.37. The new price target suggests a potential downside of 8.47% from the current share price. Prelude Therapeutics is a clinical-stage company developing therapies for cancers with high unmet need.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 5:00 pm

CSGP

Over the past 15 years, CoStar Group (NASDAQ:CSGP) has yielded an average annual return of 25.08%, outperforming the market. A $1000 investment in CSGP 15 years ago would be worth $27,986.02 today. CoStar Group's market cap stands at $36.23 billion.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 5:00 pm

MSCI

Over the past 10 years, MSCI (NYSE:MSCI) has significantly outperformed the market, with an average annual return of 28.74%. A $1000 investment in MSCI a decade ago would now be worth $12,607.44. MSCI's market capitalization currently stands at $42.88 billion.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 5:00 pm

MCOM

Shares of micromobility.com (MCOM) are trading lower following the announcement of a Nasdaq delisting notice. The company also postponed its special meeting of stockholders and withdrew its request for a reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:59 pm

XPON

Expion360, Inc (NASDAQ:XPON) announced its entry into the home energy storage market with the launch of two premium lithium iron phosphate (LiFePO4) battery storage solutions. These products are aimed at residential and small business customers to help create stable micro-energy grids and mitigate power fluctuations and outages. The company anticipates that these products will qualify for incentives under California's Self-Generation Incentive Program and federal tax credits. Orders for the new products will start in Q1 FY24, with shipments beginning in Q2 FY24. Following the announcement, XPON shares rose by 5.39% to $4.69.

Portfolio Pulse from Shivani Kumaresan

December 19, 2023 | 4:57 pm

INBS

Intelligent Bio Solutions' stock is up following the announcement that its Intelligent Fingerprinting Drug Screening Solution has received accreditation from the National Association of Testing Authorities.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:56 pm

ALB

LTHM

Allkem's shareholders approved a $10.6 billion merger with Livent, forming Arcadium Lithium, the world's third-largest lithium company. Livent shareholders will receive 2.406 shares for each share owned, while Allkem shareholders will own 56% of the new entity. Piper Sandler downgraded Livent from Neutral to Underweight with a price target cut from $18 to $15 due to a significant drop in lithium prices and potential pressure on contract structures. The lithium market faces oversupply and weakened demand, but long-term prospects remain positive due to the green energy transition and EV demand growth.

Portfolio Pulse from Stjepan Kalinic

December 19, 2023 | 4:53 pm

ProSumnus

ProSumnus shares are up following a publication in the Cureus Journal of Medical Science, which highlighted the effectiveness of the company's precision oral appliance therapy in treating Obstructive Sleep Apnea (OSA).

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:53 pm